|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit (loss) | |||||
| Operating expenses | |||||
| General and administrative expenses | |||||
| Research and development | |||||
| Consulting fees (see Note 4) | |||||
| Legal and accounting fees | |||||
| Audit fees | |||||
| Depreciation and amortization expense | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense) | |||||
| Other Income | |||||
| Gain on extinguishment of debt | |||||
| Interest expense | |||||
| Gain/Loss on change of derivative liability | |||||
| Loss on forgiveness of debt | |||||
| Settlement expense | |||||
| Financing incentive expense | |||||
| Total other income (expense) | |||||
| Net loss before tax provision | |||||
| Tax provision | |||||
| Net loss from discontinued operations before tax provision | |||||
| Tax provision for discontinued operations | |||||
| Net loss | |||||
| Net loss per common share from continuing operations - basic and diluted | |||||
| Net loss per common share from discontinued operations- basic and diluted | |||||
| Net loss per common share - basic and diluted | |||||
| Weighted average number of common shares outstanding - basic and diluted | |||||
| Net loss per share - basic and diluted | |||||
| Weighted average number of common shares - basic | |||||
Loading...